KITE
Kite Pharma Inc
Clinical-stage biopharmaceutical company developing cancer immunotherapies
CUSIP: 49803L109HealthcareUS1 holder
Total Value
$137.67M
Total Shares
2.47M
Net Share Change
+1.80M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$137.67M2.47M shares
ADD+1.80M(+265.0%)